Health
New hope a common drug could delay dementia – The Australian Financial Review
There are high hopes that a drug, shown to slow dementia in people with diabetes, will do the same for older people in general.
This is at least double the rate in people without diabetes. It is thought type 2 diabetes increases the dementia risk by promoting degenerative pathways in the brain and nerves.
The study, conducted by the Garvan Institute and the Centre for Healthy Brain Ageing, UNSW Sydney (CHeBA), was published on Thursday in the leading journal Diabetes Care.
Drug with multiple benefits
Like aspirin, metformin is emerging as a drug with multiple benefits. While it has been used as a frontline treatment f…
-
Business20 hours agoBattle of the ASX ETFs: Why has VGS outperformed VTS this year?
-
Business19 hours ago5 things to watch on the ASX 200 on Monday 7 April 2025
-
General6 hours agoDefence minister won’t say if security agencies or Trump administration pushed for Darwin Port backflip
-
Noosa News16 hours agoMeasles alert: Australia Zoo, Hospital ED, Sushi Hub, Holey Moley Mini Golf and train stations among QLD infection sites